Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
3.900
+0.030 (0.78%)
Oct 28, 2026, 10:24 AM EDT - Market open

Sionna Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
1761,836---
Market Cap Growth
-89.81%----
Enterprise Value
-841,520---
Last Close Price
3.8741.14---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
0.665.98---
P/TBV Ratio
0.665.98---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.030.030.060.31-
Net Debt / Equity Ratio
-0.98-0.98-0.95-0.82-1.04
Net Debt / EBITDA Ratio
2.393.422.270.562.00
Net Debt / FCF Ratio
3.414.523.000.632.18
Quick Ratio
19.5720.1414.164.7910.01
Current Ratio
20.0520.6114.494.8810.16
Return on Equity (ROE)
-32.34%-31.79%-61.44%-83.45%-
Return on Assets (ROA)
-21.54%-21.74%-37.10%-45.16%-
Return on Capital Employed (ROCE)
-40.20%-28.30%-40.20%-114.60%-52.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-55.60%-4.10%---
FCF Yield
-43.55%-3.63%---
Buyback Yield / Dilution
-124.56%-935.60%-31.56%-13.80%-
SEC Filings: 10-K · 10-Q